PathAI Receives FDA Clearance for AISight Dx Platform
PathAI has received FDA 510(k) clearance for its AISight Dx digital pathology platform, enabling its use in primary diagnosis.
Read MorePosted by Chris Wolski | Jul 1, 2025 | Analytical Software Systems |
PathAI has received FDA 510(k) clearance for its AISight Dx digital pathology platform, enabling its use in primary diagnosis.
Read MorePosted by Chris Wolski | Jun 30, 2025 | Tissue Processing |
Amsbio has launched Collagenase and Neutral Protease NB enzymes to support high-purity, regulatory-compliant tissue dissociation workflows.
Read MorePosted by Chris Wolski | Jun 23, 2025 | Kidney Disease |
A pilot program using Healthy.io’s FDA-cleared smartphone-powered Minuteful Kidney test significantly improved CKD screening and diagnosis.
Read MorePosted by Chris Wolski | Jun 19, 2025 | Lab Automation |
A new survey finds that data overload remains a top challenge for labs, but is also an opportunity for AI-driven transformation.
Read MorePosted by Chris Wolski | Jun 12, 2025 | Digital Pathology |
Laboratory leaders see digital pathology and AI as essential for driving precision medicine and long-term transformation in the industry.
Read More